Email updates

Keep up to date with the latest news and content from BMC Medicine and BioMed Central.

Journal App

google play app store
Open Access Email this article to a friend

Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?

Iakov N Rudenko, Ruth Chia and Mark R Cookson*

BMC Medicine 2012, 10:20  doi:10.1186/1741-7015-10-20

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Medicine's emails?